Dr. Eugene Holuka
Board Member
Citius Oncology, Inc. (CTOR)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Eugene Holuka
Dr. Eugene Holuka is recorded as Board Member at Citius Oncology, Inc. (CTOR). Citius Oncology, Inc. reported in an 8-K filed August 5, 2024 that Dr. Eugene Holuka was appointed Director (Class II).
“a proposal to approve by ordinary resolution, the eight (8) persons listed below be elected to serve on New Citius Oncology Board upon the consummation of the Business Combination to serve staggered terms until the 2025 (Class I), 2026 (Class II) and 2027 (Class III) annual meetings of stockholders, as applicable, or until their respective successors are duly elected and qualified or until their earlier death, resignation, retirement or removal for cause”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Citius Oncology, Inc.
Other people whose current roles at this company are on record from its filings.
- Leonard Mazur CEO, Chairman, Board Member
- Myron Holubiak Chairman, Board Member
- Jaime Bartushak CFO
- Carol Webb Board Member
- Dennis M. McGrath Board Member
- Dennis McGrath Board Member
- Eugene Holuka Board Member
- Joel Mayersohn Board Member
- Jonathan Peri Board Member
- Robert Smith Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.